Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Percy

Showing results (101-110 of 227) with videos related to

Pageof 23
Sort By:
Frontiers in Oncology|November 5, 2019
Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal CancersCharles A Kunos, Stephen J Andrews, Kathleen N Moore, et al.
Nursing Research|July 20, 2006
The chinese version of the decisional balance scale: further validationHuey-Shys Chen, Jiunn-Jye Sheu, Melanie S Percy, et al.
Melanoma Research|February 16, 2013
Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011Jason J Luke, Lawrence V Rubinstein, Gary L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanibKostandinos Sideras, Michael E Menefee, Jill K Burton, et al.
Leukemia & Lymphoma|July 16, 2005
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology GroupDouglas P Olson, Barbara J Taylor, Mei La, et al.
Cancer Letters|February 2, 2024
Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patientsMorgan A Butrovich, Jiyue Qin, Xiaonan Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Design issues of randomized phase II trials and a proposal for phase II screening trialsLawrence V Rubinstein, Edward L Korn, Boris Freidlin, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2026
Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigationHeekyung Lee, Allison Dunn, Sarah E Taylor, et al.
Journal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
Environmental Health Perspectives|April 30, 2016
The Association between Dust Storms and Daily Non-Accidental Mortality in the United States, 1993-2005James Lewis Crooks, Wayne E Cascio, Madelyn S Percy, et al.
Pageof 23

Showing results (101-110 of 227) with videos related to

Sort By:
Pageof 23
Frontiers in Oncology|November 5, 2019
Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal CancersCharles A Kunos, Stephen J Andrews, Kathleen N Moore, et al.
Nursing Research|July 20, 2006
The chinese version of the decisional balance scale: further validationHuey-Shys Chen, Jiunn-Jye Sheu, Melanie S Percy, et al.
Melanoma Research|February 16, 2013
Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011Jason J Luke, Lawrence V Rubinstein, Gary L Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanibKostandinos Sideras, Michael E Menefee, Jill K Burton, et al.
Leukemia & Lymphoma|July 16, 2005
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology GroupDouglas P Olson, Barbara J Taylor, Mei La, et al.
Cancer Letters|February 2, 2024
Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patientsMorgan A Butrovich, Jiyue Qin, Xiaonan Xue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Design issues of randomized phase II trials and a proposal for phase II screening trialsLawrence V Rubinstein, Edward L Korn, Boris Freidlin, et al.
Cancer Chemotherapy and Pharmacology|May 20, 2026
Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigationHeekyung Lee, Allison Dunn, Sarah E Taylor, et al.
Journal of Biopharmaceutical Statistics|April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experienceElisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
Environmental Health Perspectives|April 30, 2016
The Association between Dust Storms and Daily Non-Accidental Mortality in the United States, 1993-2005James Lewis Crooks, Wayne E Cascio, Madelyn S Percy, et al.
Pageof 23